Evidence map›Paper›PMID 34762147›Full record

ArticlePsychopharmacology2022

5-HT

Oliver Härmson, Laura L Grima, Marios C Panayi, Masud Husain, Mark E Walton

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Psychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Nucleus accumbens D1-receptors regulate and focus transitions to reward-seeking action.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Oliver HärmsonDepartment of Experimental Psychology, University of Oxford, Oxford, OX1 3SR, UK. oliver.harmson@psy.ox.ac.uk.ORCID http://orcid.org/0000-0003-0556-1539
Laura L GrimaDepartment of Experimental Psychology, University of Oxford, Oxford, OX1 3SR, UK. grimal@janelia.hhmi.org.
Marios C PanayiDepartment of Experimental Psychology, University of Oxford, Oxford, OX1 3SR, UK.
Masud HusainDepartment of Experimental Psychology, University of Oxford, Oxford, OX1 3SR, UK.
Mark E WaltonDepartment of Experimental Psychology, University of Oxford, Oxford, OX1 3SR, UK. mark.walton@psy.ox.ac.uk.
University of Oxford · GBJanelia Research Campus · USNational Institute on Drug Abuse · US

Funding

clarendon fund SFF1819_CB2_MSD_1196514economic and social research council ES/J500112/1sihtasutus archimedes Kristjan JaaguWellcome TrustWellcome Trust 202831/Z/16/ZWellcome Trust 206330/Z/17/ZWellcome Trust WT090051MA
6 · The paper itself

Abstract

The serotonin (5-HT) system, particularly the 5-HT

Indexed as

Receptor, Serotonin, 5-HT2CSerotoninAnimalsMotivationNucleus AccumbensRatsRewardReceptor, Serotonin, 5-HT2CSerotonin5-HT2C receptorAmphetamineBehavioural controlGo/No-GoNucleus accumbens core

Identifiers

PMID34762147
PMCPMC8770415
OpenAlexW3210129583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.